As exemplified here, the 11q23 KMT2A(MLL) breakpoint FISH probe for AML used as recommended by the WHO, did not detect the fusion partners in Case 1, thereby limiting its clinical utility. Here, KMT2A is linked to acute myeloid leukemia.